FDA
-
-
-
-
-
-
-
Zynex (ZYXI) Announces Completion of Its Laser Pulse Oximetry Trial
-
-
-
-
-
-
-
Zynex Obtains FDA clearance for new Pain Management Device
-
-
-
-
-
-
-
Zynex, Inc. (ZYXI) Submits FDA Application for its Next Generation NMES Device
-
-
-
-
-
-
-
Zynex Reports Preliminary Second Quarter 2023 Results
-
-
-
-
-
-
-
Zynex, Inc. (ZYXI) Reports Prelim Q1 Revenue of $30.5M-$31.5M, Adjusted EBITDA of $3M-$4M
-
-
-
-
-
-
-
Zynex, Inc. (ZYXI) Acquires Kestrel Labs for $31M in Cash and Stock
-
-
-
-
-
-
-
Zynex Announces a Second Utility Patent for Its Blood Volume Monitor
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

